The Green Cross Corporation

Daisuke Satoh

Yoshio Arakawa

Yasuo Ueda

Yoshio Kagitani

Nobuhiko Komatsu

Atuyuki Takanabe

Tadakazu Suyama

Satoshi Funakoshi

Yahiro Uemura

Eiji Sako

Novel 5,10,11,11a-tetrahydro-8-methyl-11-sulfo or sulfino-1H-pyrrolo[2,1-c][1,4]-benzodiazepin-2-acrylamides which have antitumor activity and low toxicity are prepared by reacting corresponding 11-reactive compound with a reactive sulfur compound to form 11-sulfino compounds and, if desired, oxidizing the 11-sulfino compounds to obtain 11-sulfo compound.

Pyrrolo-benzodiazepine compounds and anti-tumor composition thereof

New organic dibasic acid half esters of 7-ketocholesterol and of 7-hydroxycholesterol represented by the general formula ##STR1## (wherein R.sub.1 is .dbd.O or --OH and R.sub.2 is a C.sub.1 -C.sub.5 alkylene group or a phenylene group) and physiologically acceptable salts thereof. These compounds are effective as an immunosuppressive or an anti-inflammatory agent.

Process for the preparation of cholesterol derivatives

Novel perhydro-1H-pyrrolo[2,1-C][1,4]benzodiazepin-5-one compounds having antitumor activity, perhydro-1H-pyrrolo[2,1-C][1,4]-benzodiazepin-5,11-dione, compounds which are synthetic intermediate of the former, and processes for producing these compounds.

Pyrrolo benzodiazepine compounds

Novel perhydro-1H-pyrrolo[2,1-C][1,4]benzodiazepin-5-one compounds having antitumor activity, perhydro-1H-pyrrolo[2,1-C][1,4]-benzodiazepin-5,11-dione compounds which are synthetic intermediate of the former, and processes for producing these compounds.

Growing community of inventors

Tokushima, Japan

Daisuke Satoh